1 / 20

Medicine used in the Treatment of Obesity

Medicine used in the Treatment of Obesity. Elaine Neil Lead Pharmacist North Aberdeenshire LCHP. Medicine. At one time 3 medicines licensed Orlistat Xenical - POM Alli - OTC. Orlistat. Promotes loss of weight by preventing the digestion and absorption of fat

leone
Download Presentation

Medicine used in the Treatment of Obesity

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Medicine used in the Treatment of Obesity Elaine Neil Lead Pharmacist North Aberdeenshire LCHP

  2. Medicine At one time 3 medicines licensed • Orlistat Xenical - POM Alli - OTC

  3. Orlistat • Promotes loss of weight by preventing the digestion and absorption of fat • Inhibitor of GI lipases acting in stomach and small intestine • Reduces absorption of dietary fat by around 25-30% • The unabsorbed fat is excreted in the stool.

  4. ContraindicationsSee BNF/SPC • Hypersensitivity • Chronic malabsorption • Cholestasis • Breast-feeding • Caution in pregnant women • The effect of orlistat in patients with hepatic and/or renal impairment, children and elderly patients has not been studied.

  5. Side – effectsSee BNF/SPC • Liquid or oily stools / Oily leakage from rectum • Flatulence and Bloating/ abdominal pain • Faecal urgency • Faecal incontinence • Dyspepsia Menstrual disturbances • Headache Tooth disorder • Anxiety Gingival disorder • Fatigue Influenza • Respiratory infection Urinary tract infection • Hypoglycaemia

  6. Drug InteractionsSee BNF/SPC • Ciclosporin Anti-epileptics • Fat soluble vitamins Amiodarone • Levothyroxine • Warfarin – monitor INR • Oral contraceptives – diarrhoea

  7. Orlistat - Xenical Dose • 120mg taken with water immediately before, during or up to one hour after main meals. • Max dose 360mg daily. • Doses above 120 mg three times daily have not been shown to provide additional benefit.

  8. Orlistat • Take with calorie controlled diet, 30% calories from fat, distributed over 3 main meals. • Omit dose if no main meal taken or no fat content. • Increase in faecal fat 24 to 48 hours after dosing, levels return to pre-treatment levels, within 48 - 72 hours.

  9. Eligible Patients • BMI 30kg/m2 or greater • BMI 28kg/m2 or greater with risk factors diabetes coronary heart disease hypertension hypercholestraemia

  10. Additional “treatment” Orlistat must be prescribed in conjunction with other measures to support weight loss • Diet modification • Increase in physical activity • Behaviour modification • Appropriate support and encouragement

  11. Weight Monitoring • Serious attempts to lose weight before starting • Monitor weight loss during treatment Weight loss – 5% over 3 months (lower in patients with type 2 diabetes)

  12. Weight Monitoring • Treatment with orlistat should be discontinued after 12 weeks if patients have not lost at least 5 % of the body weight measured at the start of therapy. • Stop therapy if weight loss inadequate • May get weight gain on stopping Long-term maintenance of weight lossafter a period of obesity is difficult and often unsuccessful, and thus may require sustained support.

  13. Outcomes • Pooled data from five 2 year studies with orlistat and a hypocaloric diet showed that 37 % of orlistat patients and 19 % of placebo patients demonstrated a loss of at least 5 % of their baseline body weight after 12 weeks of treatment. • Of these, 49 % of orlistat treated patients and 40 % of placebo treated patients went on to lose 10 % of their baseline body weight at one year. • Overall, after one year of treatment, the percentage of patients taking 120 mg orlistat who lost 10 % or more of their body weight was 20 % compared to 8 % of patients taking placebo. • The mean difference in weight loss with the drug compared to placebo was 3.2 kg.

  14. Xenical – prescription (POM) • Xenical 120mg capsules

  15. Alli – over the counter (OTC) • Alli 60mg capsules • Maximum 60mg three times daily • Use for 6 months • Discard any capsules stored in the carry case for more than one month.

  16. Costs • Orlistat (Xenical) – 120mg x 3 daily 28 days supply £31.63 • Alli 60mg x 3 daily 28 days supply £15- £35 Pharmacy or Internet supply

  17. NHS Grampian Spend

  18. NHS Grampian Spend 2010/11 • 9126 prescriptions • £338,643

  19. NHS Grampian Spend

  20. NHS Grampian Spend

More Related